No products in the cart.
Return To ShopNo products in the cart.
Return To Shop€40.00
ABILIFY 5 mg Bristol – Myers Squibb is an antipsychotic medication primarily used for the treatment of various mental health conditions. The active ingredient, aripiprazole, operates by modulating neurotransmission in the brain, contributing to its therapeutic advantages. This formulation is available in a 5 mg concentration, offering a targeted release method that enhances bioavailability. In the realm of sports pharmacology, its application has gained popularity among athletes searching for cognitive enhancement and stability under pressure. The drug’s characteristics appeal to a diverse range of sports enthusiasts aiming to optimize performance and alleviate mental fatigue.
Many athletes have reported several benefits associated with the use of ABILIFY 5 mg Bristol – Myers Squibb, including improved muscle growth and increased strength and endurance. The medication can help in sustaining energy levels while enhancing concentration during training sessions or competitive events. Furthermore, faster recovery post-exercise is a significant advantage, allowing athletes to maintain a rigorous training schedule without prolonged downtime. These effects collectively contribute to overall performance enhancement, making it an attractive option for individuals looking to elevate their physical capabilities.
The typical dosing regimen for ABILIFY 5 mg Bristol – Myers Squibb will vary based on individual factors, including the athlete’s body composition, metabolic rate, and experience in using performance-enhancing substances. Standard dosages may range from 5 mg to 10 mg, taken daily, but it is crucial to consider an individualized approach for optimal results. Men and women might experience different outcomes; thus, dose adjustments may be necessary. It is advisable to follow professional guidance to determine the best cycle duration, commonly lasting between four to eight weeks, ensuring safety and efficacy.
While the therapeutic effects of ABILIFY 5 mg Bristol – Myers Squibb are notable, the body may also exhibit certain reactions. Common side effects can include mild nausea, dizziness, or changes in mood. It is essential for athletes to respect recommended dosages and combine the medication thoughtfully with other substances to mitigate potential risks. Awareness of these responses allows for a balanced approach, focusing on performance while prioritizing safety and well-being.
When considering hormonal or performance enhancers, ABILIFY 5 mg Bristol – Myers Squibb may complement various anabolic agents aimed at muscle mass gain, strength enhancement, or improved definition. Effective combinations often involve drugs that promote muscle synthesis or recovery, allowing athletes to achieve balanced results. Additionally, strategic planning can help sustain the benefits post-cycle, maintaining performance levels and facilitating a smoother transition back to baseline training without significant setbacks.
ABILIFY 5 mg Bristol – Myers Squibb can conveniently be found on various platforms offering certified products. These websites prioritize reliability and quality, ensuring that athletes receive legitimate medication along with secure ordering processes. With a commitment to customer service and prompt shipping, these sources aim to provide a seamless experience for individuals seeking to incorporate this product into their performance regimen.
| Raw Material | Aripiprazol |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Monitoring blood levels is not typically required, but lipid profiles, blood glucose, and weight should be monitored |
| Also known as | OPC-14597, OPC-31 |
| Blood pressure | Can cause orthostatic hypotension |
| Trade name | Abilify, Aripiprex |
| Storage conditions | Store at room temperature, 15-30В°C (59-86В°F) |
| Chemical name | 7-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one |
| Formula | C23H27Cl2N3O2 |
| Substance class | Atypical antipsychotic |
| Main action | Dopamine D2 and serotonin 5-HT1A receptor partial agonist |
| Half-life | Approximately 75 hours |
| Dosage (medical) | Typically starts at 10-15 mg once daily for schizophrenia, 2-15 mg once daily for bipolar disorder |
| Dosage (sports) | Not applicable |
| Effects | Antipsychotic, mood stabilization, reducing symptoms of schizophrenia and bipolar disorder |
| Side effects | Anxiety, insomnia, nausea, vomiting, blurred vision, somnolence, restlessness, tremor |
| Use in sports | None |
| Manufacturer | Bristol – Myers Squibb |
| Packing | 28 tabs (5 mg/tab) |
€12.00
Reviews
There are no reviews yet.